🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for urinary bladder cancer

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer NCT03379909Phase 23 sites📍 Nijmegen📍 Rotterdam📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Metformin Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers NCT03413982n/a1 site📍 Kansas City University of Kansas Medical Center · Tests: Registry Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment NCT06679920NA2 sites📍 Amsterdam📍 Amsterdam Amsterdam UMC · Tests: Optical coherence tomography Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS) NCT06721260n/a2 sites📍 Kansas City📍 Kansas City University of Kansas Medical Center Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC) NCT07359235Phase 11 site📍 Wuhan Tongji Hospital · Tests: KD01(the recombinant oncolytic adenovirus) A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy NCT04442724NA3 sites📍 Los Angeles📍 Los Angeles📍 Boston Cedars-Sinai Medical Center · Tests: Fiducial marker placement, Multiparametric MRI (mpMRI) Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology NCT05756569Phase 24 sites📍 Atlanta📍 Atlanta📍 Atlanta Emory University · Tests: Biospecimen Collection, Computed Tomography, Enfortumab Vedotin, Magnetic Resonance Imaging, Pembrolizumab Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer NCT06889623NA1 site📍 Shanghai Changhai Hospital · Tests: Immediate postoperative chemotherapy A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) NCT07222488Phase 1, Phase 217 sites📍 Bakersfield📍 New Brunswick📍 Myrtle Beach Merck Sharp & Dohme LLC · Tests: MK-3120 CONFIRM: Magnetic Resonance Guided Radiation Therapy NCT04368702NA2 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Viewray MRIdian® Linac A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing NCT07036731NA1 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Urine biomarker -Guided without reTURBT Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle NCT07545694n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS A Study of Ward Admissions for Haematuria NCT07395037n/a1 site📍 London British Urology Researchers in Surgical Training · Tests: Inpatient work-up and management Virtual Histology of the Bladder Wall for Bladder Cancer Staging NCT04369560EARLY Phase 11 site📍 Pittsburgh Jodi Maranchie · Tests: Magnetic Resonance Imaging, Gadobutrol intravesical administration (4mM), Ferumoxytol intravesical administration (5 mM) Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer NCT06441110Phase 31 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Tislelizumab in Combination with Bacillus Calmette-Guérin Bladder EpiCheck European Haematuria Study NCT06818136n/a5 sites📍 Dunfermline📍 Cambridge📍 Edinburgh Nucleix Ltd. · Tests: Bladder EpiCheck Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy NCT07144319n/a12 sites📍 Tampa📍 Iowa City📍 Ann Arbor Photocure Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial NCT07726602n/a1 site📍 Portland OHSU Knight Cancer Institute · Tests: Non-Interventional Study Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer NCT06394570Phase 1, Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Enfortumab vedotin Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder NCT03108196NA1 site📍 Guangzhou Zhujiang Hospital · Tests: sigmoid, ileal A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC NCT05410730Phase 1, Phase 21 site📍 Beijing Shanghai Hengrui Pharmaceutical Co., Ltd. · Tests: SHR-1501 Bladder Bank (a Prospective Banking Study) NCT06109857n/a1 site📍 Rochester Mayo Clinic · Tests: Non-Interventional Study Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia NCT05397262NA1 site📍 Erlangen University of Erlangen-Nürnberg Medical School · Tests: Hyperthermia, Radiotherapy, Chemotherapy 5-Fluorouracil, Chemotherapy Cisplatin Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer NCT07187635NA7 sites📍 Nanchang📍 Guangzhou📍 Xingtai Tianjin Medical University Second Hospital · Tests: Second Transurethral Resection of Bladder Tumor (re-TURBT), utDNA Testing (Urine Tumor DNA Detection) A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies NCT04923178n/a1 site📍 Bethesda National Cancer Institute (NCI) Prehabilitation in High-risk Oncologic Surgery NCT07638410NA1 site📍 Philadelphia Fox Chase Cancer Center · Tests: Multidisciplinary Prehabilitation Program Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer. NCT07073703NA2 sites📍 Saint-Etienne📍 Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne · Tests: APA, Therapeutic education workshops, DAPAP Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer NCT06732531Phase 1, Phase 26 sites📍 Beijing📍 Xiamen📍 Changsha Zhuhai Beihai Biotech Co., Ltd · Tests: BH011 Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051n/a1 site📍 Austin Natera, Inc.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy